Drugs / CART22 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02588456 | Oct 2015 → Sep 2017 | B-cell acute lymphoblastic leukemia | University of Pennsylvania | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CART22 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02588456 ↗ |
| Modality | Cell therapy | “CAR T cell therapies” PMID 33888899 ↗ Apr 2021 |
| Route | Intravenous | “administered by IV infusion.” NCT02588456 ↗ |
| Target | CD22 | “T cells bearing a 4-1BB-based, CD22-targeting CAR” PMID 33888899 ↗ Apr 2021 |